Skip to main content
Intermediate Technical IVT

Poorly Differentiated

A histologic grade indicating high-grade neuroendocrine tumors with aggressive behavior and poor prognosis.

Full Definition

Poorly differentiated is a histopathologic classification for high-grade neuroendocrine tumors (Grade 3) characterized by high mitotic rates, elevated Ki-67 proliferation indices, and lack of organized neuroendocrine architecture. These tumors typically have mitotic counts exceeding 20 per 10 HPF and Ki-67 indices greater than 20%. Poorly differentiated neuroendocrine carcinomas are distinguished from well- and moderately-differentiated neuroendocrine tumors by their aggressive clinical behavior, tendency for early metastasis, and generally poor response to conventional NET therapies. They often require platinum-based chemotherapy regimens similar to those used for other high-grade carcinomas.

Usage

Usage note: Hyphenate when used as a compound adjective before a noun.

In Context

  • "Histologic examination revealed a poorly differentiated neuroendocrine carcinoma with extensive necrosis." — Pathology report
  • "The poorly differentiated tumor required aggressive chemotherapy rather than standard somatostatin analog therapy." — Treatment planning

Also known as

high-grade Grade 3

Contrasted with

well-differentiated moderately differentiated

Don't confuse with

moderately differentiated undifferentiated

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON